Stem, Inc. (NYSE:STEM) Given Consensus Recommendation of “Hold” by Analysts

Shares of Stem, Inc. (NYSE:STEMGet Free Report) have been given a consensus recommendation of “Hold” by the nine ratings firms that are presently covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $1.11.

A number of equities research analysts have commented on STEM shares. Roth Mkm increased their target price on shares of Stem from $0.35 to $0.40 and gave the company a “neutral” rating in a research report on Wednesday, March 5th. Piper Sandler dropped their target price on shares of Stem from $1.50 to $0.30 and set a “neutral” rating on the stock in a research report on Friday, November 22nd. UBS Group increased their target price on shares of Stem from $0.60 to $0.65 and gave the company a “buy” rating in a research report on Friday, March 7th. Finally, BMO Capital Markets dropped their target price on shares of Stem from $0.50 to $0.40 and set a “market perform” rating on the stock in a research report on Wednesday, March 5th.

Read Our Latest Analysis on Stem

Stem Stock Performance

Shares of STEM stock opened at $0.44 on Monday. The firm’s 50 day moving average price is $0.61 and its 200-day moving average price is $0.50. Stem has a one year low of $0.30 and a one year high of $2.27. The firm has a market cap of $71.57 million, a P/E ratio of -0.08 and a beta of 1.49.

Stem (NYSE:STEMGet Free Report) last announced its earnings results on Tuesday, March 4th. The company reported ($0.12) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.04. Stem had a negative net margin of 328.11% and a negative return on equity of 275.79%. The firm had revenue of $55.83 million for the quarter, compared to the consensus estimate of $47.89 million. During the same period in the prior year, the firm earned ($0.21) EPS. As a group, research analysts predict that Stem will post -0.52 EPS for the current fiscal year.

Institutional Trading of Stem

Hedge funds have recently made changes to their positions in the company. Virtu Financial LLC acquired a new stake in shares of Stem in the 3rd quarter worth $25,000. Aries Wealth Management increased its holdings in shares of Stem by 100.0% in the 4th quarter. Aries Wealth Management now owns 50,000 shares of the company’s stock valued at $30,000 after purchasing an additional 25,000 shares in the last quarter. Creative Planning increased its holdings in shares of Stem by 177.1% in the 3rd quarter. Creative Planning now owns 123,521 shares of the company’s stock valued at $43,000 after purchasing an additional 78,940 shares in the last quarter. Balyasny Asset Management L.P. increased its holdings in shares of Stem by 569.6% in the 4th quarter. Balyasny Asset Management L.P. now owns 121,381 shares of the company’s stock valued at $73,000 after purchasing an additional 103,254 shares in the last quarter. Finally, Barclays PLC increased its holdings in shares of Stem by 213.1% in the 3rd quarter. Barclays PLC now owns 235,336 shares of the company’s stock valued at $81,000 after purchasing an additional 160,165 shares in the last quarter. Institutional investors and hedge funds own 61.63% of the company’s stock.

About Stem

(Get Free Report

Stem, Inc operates as a digitally connected, intelligent, and renewable energy storage network provider worldwide. The company offers energy storage hardware sourced from original equipment manufacturers (OEMs); edge hardware to aid in the collection of site data and real-time operation and control of the site and other optional equipment; and Athena, a software platform, which offers battery hardware and software-enabled services to operate the energy storage systems.

Featured Stories

Analyst Recommendations for Stem (NYSE:STEM)

Receive News & Ratings for Stem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stem and related companies with MarketBeat.com's FREE daily email newsletter.